As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.
13 Analysts have issued a Ebos Group forecast:
13 Analysts have issued a Ebos Group forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | 14,080 14,080 |
7%
7%
|
|
| Gross Profit | 1,879 1,879 |
0%
0%
|
|
| EBITDA | 654 654 |
7%
7%
|
|
| EBIT (Operating Income) EBIT | 486 486 |
12%
12%
|
|
| Net Profit | 247 247 |
21%
21%
|
|
In millions NZD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is a marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. The company sources and supplies a range of surgical, medical, and pharmaceutical products. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics and Clinect.
| Head office | Australia |
| CEO | Mr. Cullity |
| Website | www.ebosgroup.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


